91 related articles for article (PubMed ID: 8736825)
1. Platelet membrane glycoprotein IV (CD36) is involved in arachidonic acid induced-platelet aggregation.
Dutta-Roy AK; Crosbie LC; Gordon MJ; Campbell FM
Biochem Soc Trans; 1996 May; 24(2):167S. PubMed ID: 8736825
[No Abstract] [Full Text] [Related]
2. Stimulation of platelet glycoprotein IIb-IIIa (alpha IIb beta 3-integrin) functional activity by a monoclonal antibody to the N-terminal region of glycoprotein IIIa.
Mazurov AV; Khaspekova SG; Byzova TV; Tikhomirov OYu ; Berndt MC; Steiner B; Kouns WC
FEBS Lett; 1996 Aug; 391(1-2):84-8. PubMed ID: 8706936
[TBL] [Abstract][Full Text] [Related]
3. Normal aggregations of glycoprotein IV (CD36)-deficient platelets from seven healthy Japanese donors.
Yamamoto N; Akamatsu N; Yamazaki H; Tanoue K
Br J Haematol; 1992 May; 81(1):86-92. PubMed ID: 1381610
[TBL] [Abstract][Full Text] [Related]
4. A novel role for CD36 in VLDL-enhanced platelet activation.
Englyst NA; Taube JM; Aitman TJ; Baglin TP; Byrne CD
Diabetes; 2003 May; 52(5):1248-55. PubMed ID: 12716760
[TBL] [Abstract][Full Text] [Related]
5. Antibodies to CD36 (GPIV) inhibit platelet adhesion to subendothelial surfaces under flow conditions.
Diaz-Ricart M; Tandon NN; Gómez-Ortiz G; Carretero M; Escolar G; Ordinas A; Jamieson GA
Arterioscler Thromb Vasc Biol; 1996 Jul; 16(7):883-8. PubMed ID: 8673564
[TBL] [Abstract][Full Text] [Related]
6. Characterization of two vaccinia CD36 recombinant-virus-generated monoclonal antibodies (10/5, 13/10): effects on malarial cytoadherence and platelet functions.
Daviet L; Craig AG; McGregor L; Pinches R; Wild TF; Berendt AR; Newbold CI; McGregor JL
Eur J Biochem; 1997 Jan; 243(1-2):344-9. PubMed ID: 9030758
[TBL] [Abstract][Full Text] [Related]
7. Quantitative and functional studies on platelet glycoprotein IV.
Legrand C
Blood; 1991 Aug; 78(3):851-2. PubMed ID: 1713517
[No Abstract] [Full Text] [Related]
8. Effect of pyridoxal-5'-phosphate on aggregation of platelets from stored human concentrates induced by arachidonic acid.
Nolan ML; Harrington MG; Eljamil A
Biochem Soc Trans; 1996 Feb; 24(1):95S. PubMed ID: 8674780
[No Abstract] [Full Text] [Related]
9. Nonreceptor interactions in the pharmacology of blood platelets.
Nosál R; Jancinová V
Gen Physiol Biophys; 1999 Oct; 18 Spec No():120-5. PubMed ID: 10703730
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of platelet aggregation and arachidonic acid metabolism by B-carboline alkaloids.
Saeed SA; Simjee RU; Farnaz S; Gilani AH; Siddiqui S; Siddiqui BS; Begum S; Faizi S; Zia A
Biochem Soc Trans; 1993 Nov; 21(4):461S. PubMed ID: 8132029
[No Abstract] [Full Text] [Related]
11. A new role for P-selectin in shear-induced platelet aggregation.
Merten M; Chow T; Hellums JD; Thiagarajan P
Circulation; 2000 Oct; 102(17):2045-50. PubMed ID: 11044418
[TBL] [Abstract][Full Text] [Related]
12. Platelets lacking functional CD36 (glycoprotein IV) show reduced adhesion to collagen in flowing whole blood.
Diaz-Ricart M; Tandon NN; Carretero M; Ordinas A; Bastida E; Jamieson GA
Blood; 1993 Jul; 82(2):491-6. PubMed ID: 7687161
[TBL] [Abstract][Full Text] [Related]
13. Effects of atorvastatin on ADP-, arachidonic acid-, collagen-, and epinephrine-induced platelet aggregation.
Zhao L; Liu D; Liu B; Hu H; Cui W
J Int Med Res; 2017 Feb; 45(1):82-88. PubMed ID: 27913744
[TBL] [Abstract][Full Text] [Related]
14. CD36 associates with CD9 and integrins on human blood platelets.
Miao WM; Vasile E; Lane WS; Lawler J
Blood; 2001 Mar; 97(6):1689-96. PubMed ID: 11238109
[TBL] [Abstract][Full Text] [Related]
15. Platelet function tests using platelet aggregometry: need for repetition of the test for diagnosis of defective platelet function.
Ghosh K; Nair S; Kulkarni B; Khare A; Shetty S; Mohanty D
Platelets; 2003 Sep; 14(6):351-4. PubMed ID: 14602548
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effects of H2-receptor antagonists on platelet function in vitro.
Nakamura K; Kariyazono H; Shinkawa T; Yamaguchi T; Yamashita T; Ayukawa O; Moriyama Y; Yotsumoto G; Toyohira H; Taira A; Yamada K
Hum Exp Toxicol; 1999 Aug; 18(8):487-92. PubMed ID: 10462360
[TBL] [Abstract][Full Text] [Related]
17. Platelet function deficiency in Duchenne muscular dystrophy.
Forst J; Forst R; Leithe H; Maurin N
Neuromuscul Disord; 1998 Feb; 8(1):46-9. PubMed ID: 9565990
[TBL] [Abstract][Full Text] [Related]
18. Distinct roles of GPVI and integrin alpha(2)beta(1) in platelet shape change and aggregation induced by different collagens.
Jarvis GE; Atkinson BT; Snell DC; Watson SP
Br J Pharmacol; 2002 Sep; 137(1):107-17. PubMed ID: 12183336
[TBL] [Abstract][Full Text] [Related]
19. Effects of combination therapy with low-dose aspirin and warfarin on platelet functions after heart valve replacement.
Kobune K; Inoue M; Morikawa M; Tsuboi M; Takanami Y; Iwane Y; Kudo T
Res Commun Chem Pathol Pharmacol; 1991 Nov; 74(2):153-65. PubMed ID: 1811279
[TBL] [Abstract][Full Text] [Related]
20. Platelet aggregation testing in platelet-rich plasma: description of procedures with the aim to develop standards in the field.
Zhou L; Schmaier AH
Am J Clin Pathol; 2005 Feb; 123(2):172-83. PubMed ID: 15842039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
